Publication
Limitations and perceived delays for diagnosis and staging of lung cancer in Portugal: A nationwide survey analysis
dc.contributor.author | Barata, Fernando | |
dc.contributor.author | Fidalgo, Paula | |
dc.contributor.author | Figueiredo, Sara | |
dc.contributor.author | Tonin, Fernanda S. | |
dc.contributor.author | Duarte-Ramos, Filipa | |
dc.date.accessioned | 2023-10-23T11:50:17Z | |
dc.date.available | 2023-10-23T11:50:17Z | |
dc.date.issued | 2021 | |
dc.description.abstract | Background: We aimed to identify the perception of physicians on the limitations and delays for diagnosing, staging and treatment of lung cancer in Portugal. Methods: Portuguese physicians were invited to participate an electronic survey (Feb-Apr-2020). Descriptive statistical analyses were performed, with categorical variables reported as absolute and relative frequencies, and continuous variables with non-normal distribution as median and interquartile range (IQR). The association between categorical variables was assessed through Pearson's chi-square test. Mann-Whitney test was used to compare categorical and continuous variables (Stata v.15.0). Results: Sixty-one physicians participated in the study (45 pulmonologists, 16 oncologists), with n = 26 exclusively assisting lung cancer patients. Most experts work in public hospitals (90.16%) in Lisbon (36.07%). During the last semester of 2019, responders performed a median of 85 (IQR 55-140) diagnoses of lung cancer. Factors preventing faster referral to the specialty included poor articulation between services (60.0%) and patients low economic/cultural level (44.26%). Obtaining National Drugs Authority authorization was one of the main reasons (75.41%) for delaying the begin of treatment. The cumulative lag-time from patients' admission until treatment ranged from 42-61 days. Experts believe that the time to diagnosis could be optimized in around 11.05 days [IQR 9.61-12.50]. Most physicians (88.52%) started treatment before biomarkers results motivated by performance status deterioration (65.57%) or high tumor burden (52.46%). Clinicians exclusively assisting lung cancer cases reported fewer delays for obtaining authorization for biomarkers analysis (p = 0.023). Higher waiting times for surgery (p = 0.001), radiotherapy (p = 0.004), immunotherapy (p = 0.003) were reported by professionals from public hospitals. Conclusions: Physicians believe that is possible to reduce delays in all stages of lung cancer diagnosis with further efforts from multidisciplinary teams and hospital administration. | pt_PT |
dc.description.sponsorship | his work was supported by AstraZeneca. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscrip | pt_PT |
dc.description.version | info:eu-repo/semantics/publishedVersion | pt_PT |
dc.identifier.citation | Barata F, Fidalgo P, Figueiredo S, Tonin FS, Duarte-Ramos F. Limitations and perceived delays for diagnosis and staging of lung cancer in Portugal: A nationwide survey analysis. PLoS One. 2021;16(6):e0252529. doi:10.1371/journal.pone.0252529 | pt_PT |
dc.identifier.doi | 10.1371/journal.pone.0252529 | pt_PT |
dc.identifier.issn | 1932-6203 | |
dc.identifier.uri | http://hdl.handle.net/10400.16/2836 | |
dc.language.iso | eng | pt_PT |
dc.peerreviewed | yes | pt_PT |
dc.publisher | Public Library of Science | pt_PT |
dc.relation.publisherversion | https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0252529 | pt_PT |
dc.rights.uri | http://creativecommons.org/licenses/by-nc/4.0/ | pt_PT |
dc.title | Limitations and perceived delays for diagnosis and staging of lung cancer in Portugal: A nationwide survey analysis | pt_PT |
dc.type | journal article | |
dspace.entity.type | Publication | |
oaire.citation.conferencePlace | United States of America | pt_PT |
oaire.citation.issue | 6 | pt_PT |
oaire.citation.startPage | e0252529 | pt_PT |
oaire.citation.title | PLOS ONE | pt_PT |
oaire.citation.volume | 16 | pt_PT |
person.familyName | Fidalgo | |
person.givenName | Paula | |
person.identifier.orcid | 0000-0002-6045-7059 | |
rcaap.rights | openAccess | pt_PT |
rcaap.type | article | pt_PT |
relation.isAuthorOfPublication | b1c895e3-9026-41d3-8cff-62c3debccfd2 | |
relation.isAuthorOfPublication.latestForDiscovery | b1c895e3-9026-41d3-8cff-62c3debccfd2 |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- Barata-2021-Limitations-and-perceived-delays-fo.pdf
- Size:
- 559.63 KB
- Format:
- Adobe Portable Document Format
License bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- license.txt
- Size:
- 1.44 KB
- Format:
- Item-specific license agreed upon to submission
- Description: